Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Leonard P
LP
Bokhorst
Unit of Clinical and Descriptive Epidemiology, ISPO, Florence, Italy.
Marco
M
Zappa
Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, USA.|Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
Sigrid V
SV
Carlsson
Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
Maciej
M
Kwiatkowski
Oncology Centre Antwerp, Antwerp, Belgium.
Louis
L
Denis
Department of Urology, Hospital Universitario de Fuenlabrada, Madrid, Spain.
Alvaro
A
Paez
Department of Urology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
Jonas
J
Hugosson
Centre for Cancer Prevention, Queen Mary University of London, London, UK.
Sue
S
Moss
School of Health Sciences, University of Tampere, Tampere, Finland.
Anssi
A
Auvinen
Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands. m.roobol@erasmusmc.nl.
Monique J
MJ
Roobol
D055088:Early Detection of Cancer / Q000379:methods*; D005060:Europe / Q000453:epidemiology; D005189:False Positive Reactions; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000401:mortality*; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D019564:Unnecessary Procedures
D017430:Prostate-Specific Antigen